Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Melanoma drug wins US approval.

× No keyword cloud information.

43 in total

1. Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase.

Authors: Luc Pilotte; Pierre Larrieu; Vincent Stroobant; Didier Colau; Eduard Dolusic; Raphaël Frédérick; Etienne De Plaen; Catherine Uyttenhove; Johan Wouters; Bernard Masereel; Benoît J Van den Eynde
Journal: Proc Natl Acad Sci U S A Date: 2012-01-30 Impact factor: 11.205

Review 2. Thyroid dysfunction from antineoplastic agents.

Authors: Ole-Petter Riksfjord Hamnvik; P Reed Larsen; Ellen Marqusee
Journal: J Natl Cancer Inst Date: 2011-10-18 Impact factor: 13.506

Review 3. Vaccine strategies for glioblastoma: progress and future directions.

Authors: Christopher Jackson; Jacob Ruzevick; Henry Brem; Michael Lim
Journal: Immunotherapy Date: 2013-02 Impact factor: 4.196

Review 4. Unmasking the immune recognition of prostate cancer with CTLA4 blockade.

Authors: Serena S Kwek; Edward Cha; Lawrence Fong
Journal: Nat Rev Cancer Date: 2012-03-01 Impact factor: 60.716

Review 5. Toward Precision Radiotherapy for Use with Immune Checkpoint Blockers.

Authors: Claire Vanpouille-Box; Silvia C Formenti; Sandra Demaria
Journal: Clin Cancer Res Date: 2017-07-27 Impact factor: 12.531

Review 6. Emerging strategies to treat rare and intractable subtypes of melanoma.

Authors: Gretchen M Alicea; Vito W Rebecca
Journal: Pigment Cell Melanoma Res Date: 2020-04-24 Impact factor: 4.693

7. Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients.

Authors: Guillermo De Velasco; Youjin Je; Dominick Bossé; Mark M Awad; Patrick A Ott; Raphael B Moreira; Fabio Schutz; Joaquim Bellmunt; Guru P Sonpavde; F Stephen Hodi; Toni K Choueiri
Journal: Cancer Immunol Res Date: 2017-02-28 Impact factor: 11.151

Melanoma drug wins US approval.